These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11828605)

  • 1. Compliance and refill pattern behavior with HMG-CoA reductase inhibitors after acute myocardial infarction.
    Coombs JH; Cornish L; Hiller P; Smith DG
    Manag Care Interface; 2002 Jan; 15(1):54-8, 60. PubMed ID: 11828605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges associated with chronic medication compliance and adherence.
    Giaquinta D
    Manag Care Interface; 2002 Jan; 15(1):51-2. PubMed ID: 11865809
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving compliance through health care system and pharmaceutical company partnerships.
    Kozma CM
    Manag Care Interface; 2003 Mar; 16(3):29-30. PubMed ID: 12715409
    [No Abstract]   [Full Text] [Related]  

  • 4. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
    Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
    Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do consumers' attitudes predict prescription purchasing behavior?
    Nair KV
    Manag Care Interface; 2003 Jun; 16(6):22-7, 55. PubMed ID: 12841073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
    Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin therapy: more than meets the eye?
    McCain J
    Manag Care; 2004 Apr; 13(4):40-9. PubMed ID: 15146720
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular morbidity associated with nonadherence to statin therapy.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW
    Pharmacotherapy; 2005 Aug; 25(8):1035-43. PubMed ID: 16207093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis.
    Choudhry NK; Avorn J; Antman EM; Schneeweiss S; Shrank WH
    Health Aff (Millwood); 2007; 26(1):186-94. PubMed ID: 17211028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of a compliance-enhancing intervention in patients with hypercholesterolemia: design and baseline results of the Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives To Achievements of LDL Goals (ORBITAL) study.
    Willich SN; Müller-Nordhorn J; Sonntag F; Völler H; Meyer-Sabellek W; Wegscheider K; Windler E; Katus H
    Am Heart J; 2004 Dec; 148(6):1060-7. PubMed ID: 15632894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of patient financial incentives on participation and outcomes in a statin pill-splitting program.
    Choe HM; Stevenson JG; Streetman DS; Heisler M; Sandiford CJ; Piette JD
    Am J Manag Care; 2007 Jun; 13(6 Part 1):298-304. PubMed ID: 17567227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a comprehensive, mail-based motivational program for patients receiving lipid-lowering therapy.
    Truppo C; Keller VA; Reusch MT; Pandya B; Bendich D
    Manag Care Interface; 2003 Mar; 16(3):35-40, 62. PubMed ID: 12715411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.
    Shrank WH; Hoang T; Ettner SL; Glassman PA; Nair K; DeLapp D; Dirstine J; Avorn J; Asch SM
    Arch Intern Med; 2006 Feb; 166(3):332-7. PubMed ID: 16476874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
    McCollam P; Etemad L
    J Invasive Cardiol; 2005 Jun; 17(6):307-11. PubMed ID: 16003005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug insight: Statin use in the elderly.
    Raffel OC; White HD
    Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):318-28. PubMed ID: 16729010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS).
    Yokoyama M; Origasa H;
    Am Heart J; 2003 Oct; 146(4):613-20. PubMed ID: 14564313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization.
    Caetano PA; Lam JM; Morgan SG
    Clin Ther; 2006 Sep; 28(9):1411-24; discussion 1410. PubMed ID: 17062314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholesterol synthesis enzyme inhibitors. An everyday life comparison of effective methods in clinical studies].
    Hennemann A
    Med Monatsschr Pharm; 2005 Sep; 28(9):328-9. PubMed ID: 16163887
    [No Abstract]   [Full Text] [Related]  

  • 19. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care.
    Taira DA; Wong KS; Frech-Tamas F; Chung RS
    Am J Manag Care; 2006 Nov; 12(11):678-83. PubMed ID: 17090224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of prescription-refill records to assess patient compliance.
    Hamilton RA; Briceland LL
    Am J Hosp Pharm; 1992 Jul; 49(7):1691-6. PubMed ID: 1621725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.